293 related articles for article (PubMed ID: 22220215)
1. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.
Carcamo WC; Satoh M; Kasahara H; Terada N; Hamazaki T; Chan JY; Yao B; Tamayo S; Covini G; von Mühlen CA; Chan EK
PLoS One; 2011; 6(12):e29690. PubMed ID: 22220215
[TBL] [Abstract][Full Text] [Related]
2. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
J Genet Genomics; 2015 Jun; 42(6):287-99. PubMed ID: 26165495
[TBL] [Abstract][Full Text] [Related]
3. Glutamine deprivation initiates reversible assembly of mammalian rods and rings.
Calise SJ; Carcamo WC; Krueger C; Yin JD; Purich DL; Chan EK
Cell Mol Life Sci; 2014 Aug; 71(15):2963-73. PubMed ID: 24477477
[TBL] [Abstract][Full Text] [Related]
4. Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures.
Keppeke GD; Andrade LE; Grieshaber SS; Chan EK
Cell Biosci; 2015; 5(1):1. PubMed ID: 25601894
[TBL] [Abstract][Full Text] [Related]
5. Molecular cell biology and immunobiology of mammalian rod/ring structures.
Carcamo WC; Calise SJ; von Mühlen CA; Satoh M; Chan EK
Int Rev Cell Mol Biol; 2014; 308():35-74. PubMed ID: 24411169
[TBL] [Abstract][Full Text] [Related]
6. Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells.
Noble JW; Hunter DV; Roskelley CD; Chan EK; Mills J
PLoS One; 2016; 11(10):e0165162. PubMed ID: 27798680
[TBL] [Abstract][Full Text] [Related]
7. Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
World J Gastroenterol; 2016 Feb; 22(6):1966-74. PubMed ID: 26877604
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructure of cytoplasmic and nuclear inosine-5'-monophosphate dehydrogenase 2 "rods and rings" inclusions.
Juda P; Smigová J; Kováčik L; Bártová E; Raška I
J Histochem Cytochem; 2014 Oct; 62(10):739-50. PubMed ID: 24980853
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs.
Keppeke GD; Calise SJ; Chan EKL; Andrade LEC
Antiviral Res; 2019 Feb; 162():130-135. PubMed ID: 30605724
[TBL] [Abstract][Full Text] [Related]
11. ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly.
Hayward D; Kouznetsova VL; Pierson HE; Hasan NM; Guzman ER; Tsigelny IF; Lutsenko S
J Biol Chem; 2019 Sep; 294(39):14454-14466. PubMed ID: 31337707
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
13. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.
Carcamo WC; Ceribelli A; Calise SJ; Krueger C; Liu C; Daves M; Villalta D; Bizzaro N; Satoh M; Chan EK
J Clin Immunol; 2013 Feb; 33(2):420-6. PubMed ID: 23100146
[TBL] [Abstract][Full Text] [Related]
14. GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.
Kofuji S; Sasaki AT
J Biochem; 2020 Oct; 168(4):319-328. PubMed ID: 32702086
[TBL] [Abstract][Full Text] [Related]
15. Interfilament interaction between IMPDH and CTPS cytoophidia.
Chang CC; Keppeke GD; Sung LY; Liu JL
FEBS J; 2018 Oct; 285(20):3753-3768. PubMed ID: 30085408
[TBL] [Abstract][Full Text] [Related]
16. Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies.
Keppeke GD; Prado MS; Nunes E; Perazzio SF; Rodrigues SH; Ferraz ML; Chan EK; Andrade LE
Clin Immunol; 2016 Dec; 173():149-156. PubMed ID: 27746381
[TBL] [Abstract][Full Text] [Related]
17. IMPDH2 forms spots at branching sites and distal ends of astrocyte stem processes.
Toyoda S; Handa T; Yong H; Takahashi H; Shiwaku H
Genes Cells; 2024 Feb; 29(2):150-158. PubMed ID: 38009721
[TBL] [Abstract][Full Text] [Related]
18. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
19. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery.
Calise SJ; Chan EKL
Autoimmun Rev; 2020 Oct; 19(10):102643. PubMed ID: 32805424
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.
Dammermann W; Polywka S; Dettmann I; Mindorf S; Komorowski L; Wehmeyer M; Schulze Zur Wiesch J; Stöcker W; Lüth S
Med Microbiol Immunol; 2017 Oct; 206(5):379-382. PubMed ID: 28815296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]